| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/01/2002 | CA2432096A1 Methods for preparing purified lipopeptides |
| 08/01/2002 | CA2426154A1 Agents and methods for promoting bone growth |
| 07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
| 07/31/2002 | EP1227321A1 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 07/31/2002 | EP1226167A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226158A1 Process for preparing peptide intermediates |
| 07/31/2002 | EP1225907A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 07/31/2002 | EP0744955B1 Cyclic heptapeptide anti-inflammatory agent |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | CN1361865A Catalytic anti-factor VIII allo-antibodies |
| 07/31/2002 | CN1361792A Cyclic peptide derivatives as inhibitors of integrin alpha/beta |
| 07/31/2002 | CN1361791A Process for deacylation of lipodepsipeptides |
| 07/31/2002 | CN1361790A Amine-modified pseudomycin compounds |
| 07/30/2002 | US6426401 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426073 Genetic engineered polypeptides |
| 07/25/2002 | WO2002057794A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/25/2002 | WO2002057313A2 Receptor-binding compounds and methods for identifying them |
| 07/25/2002 | WO2002057291A2 Hla-dr2 binding peptides |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001088160A3 Vectors for dna delivery |
| 07/25/2002 | WO2001055176A3 Methods for inhibiting smooth muscle cell proliferation |
| 07/25/2002 | WO2001025275A9 Regulatory/unfolding peptides of ezrin |
| 07/25/2002 | WO2001002001A9 PEPTIDE LIGANDS THAT BIND IgM ANTIBODIES AND BLOCK INTERACTION WITH ANTIGEN |
| 07/25/2002 | US20020099019 Used in assaying human pepsin I or human pepsinogen I to diagnose gastric diseases such as gastric cancer and gastric ulcer. |
| 07/25/2002 | US20020098524 Screening peptide library for preferential proteins; obtain library, incubate with antitarget, separate unbound peptides, incubate unbound peptides with target binding protein, detect bound peptide complexes |
| 07/25/2002 | US20020098236 Transport vectors |
| 07/25/2002 | US20020098206 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 07/25/2002 | US20020098197 Hla binding peptides and their uses |
| 07/25/2002 | US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it |
| 07/25/2002 | CA2433394A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1224469A1 Method of screening for inhibitors of asp2 |
| 07/24/2002 | EP1224318A2 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/24/2002 | EP1224290A1 Disulfide conjugated cell toxins and methods of making and using them |
| 07/24/2002 | EP1224270A1 Mimic cellulose binding domain |
| 07/24/2002 | EP1224223A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 07/24/2002 | EP1224217A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 07/24/2002 | EP1224216A1 Mage-a1 peptides presented by hla class ii molecules |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1084132B1 Redox reversible imidazole-osmium complex conjugates |
| 07/24/2002 | EP0693941B1 Radiolabeled compounds for thrombus imaging |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360593A Pseudomycin N-acyl side-chain analogs |
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1087955C Technetium-99m labeled imaging agents |
| 07/23/2002 | US6423823 Fungicidal, miticidal, and nematocidal omphalotin derivative |
| 07/23/2002 | US6423686 LHRH antagonist peptides |
| 07/23/2002 | US6423502 Method for screening candidate pesticides using a receptor that binds Bacillus thuringiensis toxin |
| 07/23/2002 | US6423333 Sealing or filling tissue defects using polyfunctional crosslinking agents and protein polymers |
| 07/23/2002 | US6423233 Purification process |
| 07/23/2002 | CA2261569C Method for mass production of antimicrobial peptide |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055554A2 Antimicrobial peptides and derived metapeptides |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055546A1 Angiotensin converting enzyme inhibitors |
| 07/18/2002 | WO2002055545A1 Antimicrobial pseudopeptides |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055543A2 Hybrid peptides for treatment of bacteremia and septicemia |
| 07/18/2002 | WO2002055537A1 Extractive purification of lipopeptide antibiotics |
| 07/18/2002 | WO2002055486A2 Triazene compounds and use thereof |
| 07/18/2002 | WO2002055185A2 Block copolymers for multifunctional self-assembled systems |
| 07/18/2002 | WO2002055111A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/18/2002 | WO2002055022A2 Active metabolite of antifungal compound |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002008198A3 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/18/2002 | WO2001068142A9 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 07/18/2002 | WO2001012668A9 Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
| 07/18/2002 | US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 07/18/2002 | DE10102404A1 Triazenverbindungen sowie deren Verwendung Triazene compounds and their use |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2444637A1 Hybrid peptides for treatment of bacteremia and septicemia |
| 07/18/2002 | CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | CA2433688A1 Extractive purification of lipopeptide antibiotics |
| 07/18/2002 | CA2433652A1 Active metabolite of antifungal compound |
| 07/18/2002 | CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | CA2429956A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222201A2 Peptides which stimulate the immune response and tissue regeneration |
| 07/17/2002 | EP1169048A4 Hyaluronic acid mimics and methods related thereto |
| 07/17/2002 | EP1100520A4 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 07/17/2002 | EP0907348B1 Tooth-cleaning agent in granular form |
| 07/17/2002 | EP0876398B1 Induction of immune response against desired determinants |
| 07/17/2002 | CN1359469A Epitopes formed by non-covalent association of conjugates |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1087631C Radiolabeled peptides for diagnosis and therapy |
| 07/17/2002 | CN1087630C Radiolabeled compounds for thrombus imaging |
| 07/16/2002 | US6420521 Short gastrointestinal peptides |
| 07/16/2002 | US6420520 Peptides and remedy for bone diseases containing the same as active ingredient |
| 07/16/2002 | US6420518 Insulin-like growth factor agonist molecules |
| 07/16/2002 | US6420169 Device for generating preferential nucleotide sequences; for use as tools drug design |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |